News & Updates

Show Multimedia Only

AI tool reads histology slides to predict lung cancer mutations

18 Oct 2024 by

DeepGEM, a novel tool that harnesses artificial intelligence (AI), delivers accurate, timely, and economical gene mutation prediction from routinely acquired histology slides, enhancing the efficiency of lung cancer mutation screening, according to a study.

18 Oct 2024

WTAP overexpression tied to poor outcomes in NSCLC

18 Oct 2024

High expression of Wilms’ tumor 1-associating protein (WTAP) in patients with nonsmall cell lung cancer (NSCLC) appears to promote poor clinical outcomes, suggests a study.

18 Oct 2024

Video consultations ease symptoms in adults with depression, anxiety

18 Oct 2024 by

An integrated mental health video consultation approach (PROVIDE model) can modestly reduce symptoms in adults with depression and anxiety disorders, a study has shown.

18 Oct 2024

Antidepressant use linked to poor muscle health, cardiometabolic risks

18 Oct 2024

Monitoring the body weight of the BMI of patients taking antidepressants does not seem to fully capture the adverse changes in body composition, a study has found. Such changes may result in a worsened cardiometabolic risk profile.

18 Oct 2024

Real-world study supports tralokinumab for difficult-to-treat AD

18 Oct 2024 by

Interim data from the real-world TRACE study confirm the benefits of the high-affinity monoclonal antibody tralokinumab for individuals with moderate-to-severe head and neck atopic dermatitis (H&N AD) after up to 9 months of treatment.

18 Oct 2024

Wet cupping therapy may help relieve migraine headaches

18 Oct 2024

Cupping therapy, especially wet cupping, appears to yield high treatment success rates, helping reduce pain intensity without increasing the risk of adverse events (AEs) among individuals with migraine headaches, according to the results of a systematic review and meta-analysis.

18 Oct 2024

Fuzuloparib ± apatinib improves PFS in BRCA-mutated metastatic breast cancer

18 Oct 2024 by

Treatment with fuzuloparib, with or without apatinib, significantly improved progression-free survival (PFS) in patients with HER2– metastatic breast cancer (mBC) harbouring germline BRCA1/2 (gBRCA1/2) mutations compared with standard chemotherapy, according to results of a phase III study presented at ESMO 2024.

18 Oct 2024

Voice-activated CBT for insomnia works for breast cancer survivors

17 Oct 2024

An in-home, voice-activated cognitive behavioural therapy for insomnia (CBT-I) program appears to help breast cancer survivors sleep, according to a study.

17 Oct 2024